Ventus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.48 Cr
as on 16-11-2024
- Satisfied Charges ₹ 5.99 M
as on 16-11-2024
About Ventus Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.48 Cr. The company has closed loans amounting to ₹5.99 M, as per Ministry of Corporate Affairs (MCA) records.
Girjesh Kumar and Shaishav Sandal serve as directors at the Company.
- CIN/LLPIN
U24132HR2011PTC097546
- Company No.
033361
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Nov 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ventus Pharmaceuticals Private Limited offer?
Ventus Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Essential & Aromatic Oils, Seeds Oil and Fruit Oils, Nutraceuticals & Dietary Supplements, Dietary Supplements, Chemical Reagents & Catalysts, Inorganic Salts, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications.
Who are the key members and board of directors at Ventus Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girjesh Kumar  | Director | 14-Nov-2011 | Current |
| Shaishav Sandal | Director | 24-Feb-2016 | Current |
Financial Performance of Ventus Pharmaceuticals.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ventus Pharmaceuticals?
Unlock access to Ventus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 10 Jun 2022 | ₹1.75 Cr | Open |
Hdfc Bank Limited Creation Date: 25 Aug 2021 | ₹3.54 Cr | Open |
Others Creation Date: 06 Mar 2017 | ₹1.86 M | Open |
How Many Employees Work at Ventus Pharmaceuticals?
Unlock and access historical data on people associated with Ventus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ventus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ventus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
